Publications by authors named "Alexander Hallner"

Claim this Profile
H
HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia.
Hana Komic, Alexander Hallner, Brwa Ali Hussein, Chiara Badami, Anne Wöhr

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.
Brwa Ali Hussein, Linnea Kristenson, Silvia Pesce, Anne Wöhr, Yarong Tian, Alexander Hallner

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.
Brwa Ali Hussein, Alexander Hallner, Lovisa Wennström, Mats Brune, Anna Martner

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.
Brwa Ali Hussein, Alexander Hallner, Lovisa Wennström, Mats Brune, Anna Martner

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.
Malin S Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B Thorén

Hum Vaccin Immunother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.
Ali A Akhiani, Alexander Hallner, Roberta Kiffin, Ebru Aydin, Olle Werlenius

Cancer Immunol Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.
Malin S Nilsson, Alexander Hallner, Mats Brune, Staffan Nilsson, Fredrik B Thorén

Br J Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.
Alexander Hallner, Elin Bernson, Brwa Ali Hussein, Frida Ewald Sander, Mats Brune

Blood· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.
Ebru Aydin, Alexander Hallner, Hanna Grauers Wiktorin, Anna Staffas, Kristoffer Hellstrand

Oncogene· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.
Elin Bernson, Alexander Hallner, Frida E Sander, Malin Nicklasson, Malin S Nilsson

Cancer Immunol Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells.
Anna Wenger, Katja Werlenius, Alexander Hallner, Fredrik Bergh Thorén, Dan Farahmand

Neoplasia· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.
Anna Rydström, Alexander Hallner, Johan Aurelius, Frida Ewald Sander, Elin Bernson

J Leukoc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.
Johan Aurelius, Alexander Hallner, Olle Werlenius, Rebecca Riise, Lars Möllgård

J Leukoc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.
Olle Werlenius, Johan Aurelius, Alexander Hallner, Ali A Akhiani, Maria Simpanen

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia.
Alexander Hallner, Johan Aurelius, Fredrik Bergh Thorén, Frida Ewald Sander, Mats Brune

Eur J Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis